Alternate Run Study

Overview

The proposed study will investigate the effect of alternating footwear model and workout-type on the occurrence of running-related pain. To achieve this goal participants will be randomly assigned into one of four different groups who will perform: 1) the same workout throughout a week in the same running shoe model, 2) alternating workout-types throughout the week in the same shoe model, 3) the same workout throughout a week in alternating shoe models, and 4) alternating workouts in alternating shoes. Participants will be characterized based on body alignment, strength, injury and training history. Pain and injury status will be monitored.

Full Title of Study: “Investigating the Effect of Alternating Training Load and Footwear Singly or in Combination in Runners: The Alternate Run Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 30, 2017

Interventions

  • Other: Alternating run training load
    • Runners will perform a variation of workouts, consisting of interval/speed work, tempo runs, and long-slow distance runs throughout each 7-day period
  • Other: Alternating footwear
    • Runners will be assigned identical training sessions over a 7-day period but will alternate use of two different models of running shoes across successive workouts (Nike Pegasus and Nike Zoom Streak). The Zoom Streak has 10mm less midsole material, a less supportive heel counter and more flexible forefoot providing a more responsive feel to the runner.
  • Other: Constant training
    • Runners will be assigned identical training sessions over a 7-day period.
  • Other: Constant footwear
    • Runners perform runs in two pairs of the same assigned neutral-cushioned running shoe (Nike Pegasus).

Arms, Groups and Cohorts

  • Active Comparator: Constant training/Constant footwear
    • Group 1 – Runners will be assigned identical training sessions over a 7-day period and will perform these runs in two pairs of the same assigned neutral-cushioned running shoe (Nike Pegasus). The weekly training volume will increase on a weekly basis in order to progressively increase training load in preparation for the half-marathon event.
  • Experimental: Alternate training/Constant footwear
    • Group 2 – Runners will perform a variation of workouts, consisting of interval/speed work, tempo runs, and long-slow distance runs throughout each 7-day period. As with Group 1, weekly training volume will increase on a weekly basis. Runners in Group 2 will perform these runs in two pairs of the same assigned neutral-cushioned running shoe (Nike Pegasus).
  • Experimental: Constant training/Alternating footwear
    • Group 3 – Runners will be assigned identical training sessions over a 7-day period but will alternate use of two different models of running shoes across successive workouts (Nike Pegasus and Nike Zoom Streak). The Zoom Streak has 10mm less midsole material, a less supportive heel counter and more flexible forefoot providing a more responsive feel to the runner.
  • Experimental: Alternating training/Alternating footwear
    • Group 4 – Runners will be assigned a variation of workouts throughout each 7-day period and will alternate use of two different models of running shoes across successive workouts (Nike Pegasus and Nike Zoom Streak).

Clinical Trial Outcome Measures

Primary Measures

  • Running injuries
    • Time Frame: 13-weeks
    • When an participant misses 3 consecutive assigned running workouts.

Secondary Measures

  • Running-related pain
    • Time Frame: 13-weeks
    • 11-point numerical rating scale of overall pain associated with running
  • Region specific running-related pain
    • Time Frame: 13-weeks
    • Numerical rating scale for pain at selected anatomical locations: gluteal, low back, groin, thigh, hamstring, knee, calf, Achilles, ankle, foot.
  • Footwear comfort
    • Time Frame: 13-weeks
    • 11-point rating of footwear comfort
  • Run Quality
    • Time Frame: 13-weeks
    • Study specific 11-point measure of how the footwear used affected each run’s quality

Participating in This Clinical Trial

Inclusion Criteria

  • Subjects in this study will include adults (men and women) between the ages of 19 and 60, have been running on a regular basis (minimum once per week) over the past 6 months, are able to run for 60 minutes continuously, could tolerate 20-40km per week in training, and have not experienced a running related injury requiring a stoppage of 2-weeks or more in the past 6 months. Only neutral and pronated foot postures (Foot Posture Index between -2 and 8) will be recruited Exclusion Criteria:

  • have a history of surgery to their plantar fascia or Achilles tendon, – have a diagnosis of osteoarthritis – or other degenerative musculoskeletal disorder - affecting the lower extremity, – take analgesic or anti-inflammatory medication 2 or more times per week over the past 4 weeks, – take part in high impact activities 2 or more times per week during the study period

Gender Eligibility: All

Minimum Age: 19 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of British Columbia
  • Collaborator
    • British Columbia Sports Medicine Research Foundation
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jack Taunton, Professor – University of British Columbia

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.